Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002265364 | SCV002547036 | uncertain significance | not provided | 2022-01-05 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Labcorp Genetics |
RCV002265364 | SCV003454210 | likely benign | not provided | 2024-07-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003101487 | SCV003748586 | uncertain significance | Inborn genetic diseases | 2021-08-12 | criteria provided, single submitter | clinical testing | The c.6738G>T (p.L2246F) alteration is located in exon 85 (coding exon 85) of the COL7A1 gene. This alteration results from a G to T substitution at nucleotide position 6738, causing the leucine (L) at amino acid position 2246 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Neuberg Centre For Genomic Medicine, |
RCV003388627 | SCV004100394 | uncertain significance | Recessive dystrophic epidermolysis bullosa | criteria provided, single submitter | clinical testing | The missense variant p.L2246F in COL7A1 (NM_000094.4) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The variant is observed in 32/30614 (0.1045%) alleles from individuals of South Asian background in the gnomAD dataset (Exome Aggregation Consortium et al., 2016), but was not seen in the homozygous state. The variant is damaging by SIFT and PolyPhen2 and the residue is conserved across species. For these reasons, this variant has been classified as Uncertain Significance. |